メニューにジャンプ コンテンツにジャンプ

トップページ > 当センターについて > 業績集 > ACC業績集 2009年

ACC業績集 2009年

英文

ACC Publications 2009

※PubMed等(外部サイト)にリンクします

  1. Gatanaga H and Oka S. Successful genotype-tailored treatment with small-dose efavirenz. AIDS (correspondence) 23: 433-434, 2009.
  2. Gatanaga H, Honda H, Tsukada K, Tanuma J, Yazaki H, Honda M, Teruya K, Kikuchi Y, and Oka S. Detection of HIV-1 load by the Roche COBAS TaqMan assay in patients with previously undetectable load by the Roche COBAS Amplicor Monitor. Clin Infect Dis (correspondence) 48: 260-262, 2009.
  3. Davaalkham J, Unenchimeng P, Baigalmaa C, Oyunbileg B, Tsuchiya K, Hachiya A, Gatanaga H, Nyamkhuu D, and Oka S. High risk status of HIV-1 in the very low epidemic country, Mongolia, 2007. Int J STD AIDS 20: 391-394, 2009.
  4. Ishizaki A, Cuong NH, Thuc PV, Trung NV, Saijoh K, Kageyama S, Ishigaki K, Tanuma J, Oka S, and Ichimura H. Profile of HIV-1 infection and genotypic resistance mutations to antiretroviral drugs in treatment-naïve HIV-1-infected individuals in Hai Phong, Viet Nam. AIDS Res Hum Retrovirus 25: 175-182, 2009.
  5. Bi X, Suzuki Y, Gatanaga H, and Oka S. High frequency and proliferation of CD4+FOXP3+ regulatory T cells in HIV-1 infected patients with low CD4 count. Eur J Immunol 39: 301-309, 2009, Epub 2008 Dec 16.
  6. Srasuebkul P, Lim PL, Lee MP, Kumarasamy N, Zhou J, Sirisanthana T, Li PC, Kamarulzaman A, Oka S, Phanuphak P, Vonthanak S, Merati TP, Chen YM, Sungkanuparph S, Tau G, Zhang F, Lee CK, Ditangco R, Pujari S, Choi JY, Smith J, Law MG. Short-term clinical disease progression in HIV-infected patients receiving combination antiretroviral therapy: results from the TREAT Asia HIV observational database. Clin Infect Dis 48: 940-950, 2009.
  7. Kawashima Y, Pfafferott K, Duda A, Matthews P, Addo M, Gatanaga H, Fujiwara M, Hachiya A, Kizumi H, Kuse N, Oka S, Brumme Z, Brumme C, Brander C, Allen T, Kaslow R, Tang J, Hunter E, Allen S, Mulenga J, Branch S, Roach T, John M, Mallal S, Heckerma D, Frater J, Prendergast A, Crawford H, Leslie A, Prado J, Ndung’u T, Phillips R, Harrigan R, Walker B, Takiguchi M, and Goulder P. Adaptation of HIV-1 to HLA I. Nature 458: 641-645, 2009, Epub 2009 Feb 25.
  8. Koizumi H, Iwatani T, Tanuma J, Fujiwara M, Izumi T, Oka S, and Takiguchi M. Escape mutation selected by Gag28-36-specific cytotoxic T cells in HLA-A*2402-positive HIV-1-infected donors. Microbes Infect 11: 198-204, 2009, Epub 2008 Nov 24.
  9. Fox Z, Phillips A, Cohen C, Neuhaus J, Baxter J, Emery S, Hirschel B, Hullsiek KH, Stephan C, Lundgren J; SMART Study Group (Honda M and Ishisaka M as members of the trial and Oka S as a principal investigator of the Sydney Regional Coordinating Center). Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS 22: 2279-2289, 2008.
  10. Mocroft A, Wyatt C, Szczech L, Neuhaus J, El-Sadr W, Tracy R, Kuller L, Shlipak M, Angus B, Klinker H, Ross M; INSIGHT SMART Study Group (Honda M and Ishisaka M as members of the trial and Oka S as a principal investigator of the Sydney Regional Coordinating Center). Interruption of antiretroviral therapy is associated with increased plasma cystatin C. AIDS 23: 71-82, 2009.
  11. Murakoshi H, Kitano M, Akahoshi T, Kawashima Y, Dohki S, Oka S, and Takiguchi M. Identification and characterization of 2 HIV-1 Gag immunodominant epitopes restricted by Asian HLA allele HLA-B*4801. Hum Immunol 70: 170-174, 2009, Epub 2009 Jan 21.
  12. Kawabata KC, Hagiwara S, Takenouchi A, Tanimura A, Tanuma J, Tachikawa N, Miwa A, and Oka S. Autologous stem cell transplantation using MEAM regimen for relapsed AIDS-related lymphoma patients who received highly active anti-retroviral therapy: a report of three cases. Intern Med 48: 111-114, 2009, Epub 2009 Jan 15.
  13. Kamimura M, Watanabe K, Kobayakawa M, Mihara F, Edamoto Y, Teruya K, Kikuchi Y, and Oka S. Absorption of lopinavir is limited within 35cm distance from Treiz ligament in the jejunum. Intern Med (Case Report) 48: 1103-1104, 2009, Epub 2009 Jun 15.
  14. Land S, Cunningham P, Zhou J, Frost K, Katzenstein D, Kantor R, Chen YM, Oka S, DeLong A, Sayer D, Smith J, Dax EM, Law M; TAQAS Laboratory Network. TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories. J Virol Methods 159: 185-93, 2009. Epub 2009 Mar 26.
  15. Zheng N, Fujiwara M, Oka S, and Takiguchi M. Strong ability of Nef-specific CD4+ cytotoxic T cells to suppress HIV-1 replication in HIV-1-infected CD4+ T cells and macrophages. J Virol 83: 7668-7677, 2009. Epub 2009 May 20.
  16. Hachiya A, Shimane K, Sarafianos SG, Kodama EN, Sakagami Y, Negishi F, Koizumi H, Gatanaga H, Matsuoka M, Takiguchi M, Oka S. Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients. Antiviral Res 82: 115-121, 2009. Epub 2009 Feb 21.
  17. Zhou J, Elliott J, Li PC, Lim PL, Kiertiburanakul S, Kumarasamy N, Merati TP, Pujari S, Chen YM, Phanuphak P, Vonthanak S, Sirisanthana T, Sungkanuparph S, Lee CK, Kamarulzaman A, Oka S, Zhang F, Tau G, Ditangco R. Risk and prognostic significance of tuberculosis in patients from The TREAT Asia HIV Observational Database. BMC Infect Dis 9: 46, 2009.
  18. Honda H, Gatanaga H, Matsumura J, Kamimura M, Goto K, Tsukada K, Honda M, Teruya K, Kikuchi Y, and Oka S. Favorable usage of non-boosted fosamprenavir in patients treated with warfarin. Int J STD AIDS (Letters to the Editor) 20: 441, 2009.
  19. Yazaki H, Goto N, Uchida K, Kobayashi T, Gatanaga H, and Oka S. Outbreak of Pneumocystis jiroveci pneumonia in renal transplant recipients: P jiroveci is contagious to the susceptible host. Transplantation 88: 380-385, 2009.
  20. Zhou J, Li PC, Kumarasamy N, Boyd M, Chen YMA, Sirisanthana T, Sungkanuparph S, Oka S, Tau G, Phanuphak P, Saphonn V, Zhang FJ, Kamarulzaman A, Lee CKC, Ditango R, Merati TP, Lim PL, Choi JY, and Pujari S on behalf of the Treat Asia HIV Observational Database. Deferred modification of antiretroviral regimen following documented treatment failure in Asia: results from The TREAT Asia HIV Observational Database (TAHOD). HIV Med 11: 31-39, 2010, Epub Jul 6, 2009.
  21. Davaalkham J, Tsuchiya K, Gatanaga H, Nyamkhuu D, and Oka S. Allele and Genotype Frequencies of Cytochrome P450 2B6 Gene in a Mongolian Population. Drug Metab Disp 37: 1991-1993, 2009, Epub Jul 6, 2009.
  22. Watanabe T, Yasuoka A, Honda H, Tanuma J, Yazaki H, Tsukada K, Honda M, Gatanaga H, Teruya K, Tachikawa N, Kikuchi Y, and Oka S. Serum (1-3) β-D-glucan as a non-invasive useful adjunctive diagnostic marker for Pneumocystis pneumonia in patients with human immunodeficiency virus. Clin Infect Dis 49: 1128-1131, 2009. Epub Sep 2, 2009.
  23. Watanabe K, Honda M, Watanabe T, Tsukada K, Teruya K, Kikuchi Y, Oks S, and Gatanaga H. Emergence of raltegravir-resistant HIV-1 in the central nerve system. Int J STD AIDS (case report) (in press)
  24. Watanabe K, Teruya K, Kikuchi Y, and Oka S. Successful treatment of ulcerous skin lesion caused by mistaken intradermal injection of BCG (Bacille de Calmette et Guerin) vaccine with anti-tuberculous drugs and systemic administration of corticosteroid. Intern Med 48:1323-5132, 2009. Epub Aug 3, 2009.
  25. Hashimoto M, Kitano M, Honda K, Koizumi H, Dohki S, Oka S, Takiguchi M. Selection of escape mutation by Pol154-162-specific cytotoxic T cells among chronically HIV-1-infected HLA-B*5401-positive individuals. Hum Immunol 71:123-127, 2010, Epub 2009 Nov 2.
  26. INSIGHT-ESPRIT Study Group (Kikuchi Y and Takano M as members of Japan National Trial Coordinating Center and Oka S as a Regional Principal Investigator). Interleukin-2 therapy in patients with HIV infection. N Engl J Med 361:1548-59, 2009.

和文

準備中

国際学会

準備中

国内学会

準備中